BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does BioGaia AB (publ) (BIOG-B) operate in?
BioGaia AB (publ) belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is BioGaia AB (publ) (BIOG-B) current stock price?
As of the latest data, BioGaia AB (publ) stock price is SEK 124.50, with a previous close of SEK 127.30. BioGaia AB (publ) lost -SEK 2.80 in the last trading session, representing a -2.2% loss.
What is BioGaia AB (publ) (BIOG-B) current market capitalization?
BioGaia AB (publ) market cap is approximately 12.26 billion.
What is BioGaia AB (publ) (BIOG-B) Earnings Per Share (EPS)?
The trailing EPS is SEK 3.87, and the forward EPS is SEK 4.84.
What is BioGaia AB (publ) (BIOG-B) Price-to-Earnings (P/E) ratio?
BioGaia AB (publ) current P/E ratio is 32.17, with a forward P/E of 25.72.
What is BioGaia AB (publ) (BIOG-B) EBITDA?
BioGaia AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 241.00 million.
Does BioGaia AB (publ) (BIOG-B) pay dividends?
Yes. BioGaia AB (publ) pays annual dividends with an annualized yield of 3.21% and an estimated annual payout of SEK 4.00 per share.
When is the next ex-dividend date for BioGaia AB (publ) (BIOG-B)?
The next ex-dividend date is scheduled for May 08, 2027.
How did BioGaia AB (publ) (BIOG-B) perform in its most recent earnings report?
In the last report (September 30, 2026), BioGaia AB (publ) posted an EPS surprise of 28.24% and a revenue surprise of 7.63%.
What is BioGaia AB (publ) (BIOG-B) beta (volatility) score?
BioGaia AB (publ) has a beta of 0.273, indicating lower volatility than the overall market.
